Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A Phase 1 Dose Escalation Study of the Safety and Pharmac... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies
0
Authors
Owen O’Connor
6 more
Owen O’Connor
•
Lori Kunkel
4 more
•
Robert Orlowski
Published
November 11, 2009
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Clinical Cancer Research
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Molecular Biology
Show all topics
DOI
10.1158/1078-0432.ccr-09-0822
